• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global fabry disease drugs market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global fabry disease drugs market 2018 – 2022 ($ million)
o 4.2 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
o 4.3 Route Of Administration Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Route Of Administration Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies – Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o 6.4 Retail pharmacies – Market size and forecast 2023-2028
o Exhibit 38: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o 6.5 Online pharmacies – Market size and forecast 2023-2028
o Exhibit 42: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 48: Chart on Route of Administration – Market share 2023-2028 (%)
o Exhibit 49: Data Table on Route of Administration – Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 50: Chart on Comparison by Route of Administration
o Exhibit 51: Data Table on Comparison by Route of Administration
o 7.3 Intravenous route – Market size and forecast 2023-2028
o Exhibit 52: Chart on Intravenous route – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Intravenous route – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Intravenous route – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Intravenous route – Year-over-year growth 2023-2028 (%)
o 7.4 Oral route – Market size and forecast 2023-2028
o Exhibit 56: Chart on Oral route – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Oral route – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Oral route – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Oral route – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 60: Market opportunity by Route of Administration ($ million)
o Exhibit 61: Data Table on Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 67: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 83: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 China – Market size and forecast 2023-2028
o Exhibit 87: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 UK – Market size and forecast 2023-2028
o Exhibit 95: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 4D Molecular Therapeutics Inc.
o Exhibit 111: 4D Molecular Therapeutics Inc. – Overview
o Exhibit 112: 4D Molecular Therapeutics Inc. – Product / Service
o Exhibit 113: 4D Molecular Therapeutics Inc. – Key offerings
o 12.4 Amicus Therapeutics Inc.
o Exhibit 114: Amicus Therapeutics Inc. – Overview
o Exhibit 115: Amicus Therapeutics Inc. – Product / Service
o Exhibit 116: Amicus Therapeutics Inc. – Key offerings
o 12.5 CHIESI Farmaceutici SpA
o Exhibit 117: CHIESI Farmaceutici SpA – Overview
o Exhibit 118: CHIESI Farmaceutici SpA – Product / Service
o Exhibit 119: CHIESI Farmaceutici SpA – Key offerings
o 12.6 Freeline Therapeutics Holdings plc
o Exhibit 120: Freeline Therapeutics Holdings plc – Overview
o Exhibit 121: Freeline Therapeutics Holdings plc – Product / Service
o Exhibit 122: Freeline Therapeutics Holdings plc – Key offerings
o 12.7 Idorsia Pharmaceuticals Ltd.
o Exhibit 123: Idorsia Pharmaceuticals Ltd. – Overview
o Exhibit 124: Idorsia Pharmaceuticals Ltd. – Product / Service
o Exhibit 125: Idorsia Pharmaceuticals Ltd. – Key offerings
o 12.8 Sangamo Therapeutics Inc.
o Exhibit 126: Sangamo Therapeutics Inc. – Overview
o Exhibit 127: Sangamo Therapeutics Inc. – Product / Service
o Exhibit 128: Sangamo Therapeutics Inc. – Key offerings
o 12.9 Sanofi SA
o Exhibit 129: Sanofi SA – Overview
o Exhibit 130: Sanofi SA – Business segments
o Exhibit 131: Sanofi SA – Key news
o Exhibit 132: Sanofi SA – Key offerings
o Exhibit 133: Sanofi SA – Segment focus
o 12.10 Takeda Pharmaceutical Co. Ltd.
o Exhibit 134: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 135: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 136: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 137: Takeda Pharmaceutical Co. Ltd. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 138: Inclusions checklist
o Exhibit 139: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 140: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 141: Research methodology
o Exhibit 142: Validation techniques employed for market sizing
o Exhibit 143: Information sources
o 13.5 List of abbreviations
o Exhibit 144: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Five forces analysis – Comparison between 2023 and 2028
Exhibits19: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits20: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits21: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits22: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits23: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits24: Chart on Market condition – Five forces 2023 and 2028
Exhibits25: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits26: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits27: Chart on Comparison by Distribution Channel
Exhibits28: Data Table on Comparison by Distribution Channel
Exhibits29: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits30: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits31: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits32: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits33: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits34: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits35: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits36: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits37: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits38: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits39: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits40: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits41: Market opportunity by Distribution Channel ($ million)
Exhibits42: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits43: Chart on Route of Administration – Market share 2023-2028 (%)
Exhibits44: Data Table on Route of Administration – Market share 2023-2028 (%)
Exhibits45: Chart on Comparison by Route of Administration
Exhibits46: Data Table on Comparison by Route of Administration
Exhibits47: Chart on Intravenous route – Market size and forecast 2023-2028 ($ million)
Exhibits48: Data Table on Intravenous route – Market size and forecast 2023-2028 ($ million)
Exhibits49: Chart on Intravenous route – Year-over-year growth 2023-2028 (%)
Exhibits50: Data Table on Intravenous route – Year-over-year growth 2023-2028 (%)
Exhibits51: Chart on Oral route – Market size and forecast 2023-2028 ($ million)
Exhibits52: Data Table on Oral route – Market size and forecast 2023-2028 ($ million)
Exhibits53: Chart on Oral route – Year-over-year growth 2023-2028 (%)
Exhibits54: Data Table on Oral route – Year-over-year growth 2023-2028 (%)
Exhibits55: Market opportunity by Route of Administration ($ million)
Exhibits56: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits58: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits59: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Chart on Geographic comparison
Exhibits61: Data Table on Geographic comparison
Exhibits62: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits71: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits72: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits75: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits76: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits77: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits79: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits80: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits81: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits83: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits84: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits85: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits86: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits87: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits88: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits89: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits90: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits91: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits92: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits93: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits94: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits95: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits96: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits97: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits98: Market opportunity By Geographical Landscape ($ million)
Exhibits99: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits100: Impact of drivers and challenges in 2023 and 2028
Exhibits101: Overview on Criticality of inputs and Factors of differentiation
Exhibits102: Overview on factors of disruption
Exhibits103: Impact of key risks on business
Exhibits104: Vendors covered
Exhibits105: Matrix on vendor position and classification
Exhibits106: 4D Molecular Therapeutics Inc. – Overview
Exhibits107: 4D Molecular Therapeutics Inc. – Product / Service
Exhibits108: 4D Molecular Therapeutics Inc. – Key offerings
Exhibits109: Amicus Therapeutics Inc. – Overview
Exhibits110: Amicus Therapeutics Inc. – Product / Service
Exhibits111: Amicus Therapeutics Inc. – Key offerings
Exhibits112: CHIESI Farmaceutici SpA – Overview
Exhibits113: CHIESI Farmaceutici SpA – Product / Service
Exhibits114: CHIESI Farmaceutici SpA – Key offerings
Exhibits115: Freeline Therapeutics Holdings plc – Overview
Exhibits116: Freeline Therapeutics Holdings plc – Product / Service
Exhibits117: Freeline Therapeutics Holdings plc – Key offerings
Exhibits118: Idorsia Pharmaceuticals Ltd. – Overview
Exhibits119: Idorsia Pharmaceuticals Ltd. – Product / Service
Exhibits120: Idorsia Pharmaceuticals Ltd. – Key offerings
Exhibits121: Sangamo Therapeutics Inc. – Overview
Exhibits122: Sangamo Therapeutics Inc. – Product / Service
Exhibits123: Sangamo Therapeutics Inc. – Key offerings
Exhibits124: Sanofi SA – Overview
Exhibits125: Sanofi SA – Business segments
Exhibits126: Sanofi SA – Key news
Exhibits127: Sanofi SA – Key offerings
Exhibits128: Sanofi SA – Segment focus
Exhibits129: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits130: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits131: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits132: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations
